Oncology CME

Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
July 15, 2021
Credits: 1.00 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer: Latest Data Informing Best Practices for Multimodal Management of Stage I-III NSCLC
Jamie E. Chaft, MD
July 12, 2021
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Gaining New Ground With Immunotherapy in the Management of Early and Advanced Gastrointestinal Cancers: Translating Progress Into Clinical Practice in Gastric, Esophageal, GEJ, and Colorectal Cancers
Jaffer A. Ajani, MD / Ian Chau, MD, FRCP
July 9, 2021
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Building Better Models for Melanoma Care: Continued Progress With Immunotherapy in Resectable and Unresectable Disease
Jason J. Luke, MD, FACP / Geoffrey T. Gibney, MD
July 7, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Evaluating the Evidence and Parsing the Practicalities of Therapeutic Choices in Advanced and Early HR+ Breast Cancer: Expert Perspectives on CDK4 and 6 Inhibitors and Other Novel Agents
Sara M. Tolaney, MD, MPH
July 7, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Innovation at Warp Speed for Multiple Myeloma: Tumor Board Insights on State-of-the-Art Care
Nina Shah, MD
July 7, 2021
Credits: 1.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
The Expanding Advanced Ovarian Cancer Treatment Palette: Candid Conversations on Bringing PARP Inhibitors Into Clinical Practice
Deborah K. Armstrong, MD
July 6, 2021
Credits: 1.50 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Tracking All the Targets in Genomically Altered NSCLC: Everything You Need to Know About Biomarker Testing and Treatment
Stephen V. Liu, MD
July 6, 2021
Credits: 1.50 CME / MOC
PVI, PeerView Institute for Medical Education
Rethinking the Care of Renal Cell Carcinoma: Expert Perspectives on Novel Agents, Combinations, and Sequencing Therapy
Toni K. Choueiri, MD
July 5, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making the Most of Treatment Advances in SCLC: New Standards, Practicalities of Care, and Hope on the Horizon
Jacob Sands, MD
July 5, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Clinical Consults on Modern AML Therapy: Where Precision Care Meets Potent Therapeutics
Gail J. Roboz, MD
July 5, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Pushing Therapeutic Boundaries in CLL: The Convergence of Targeted Therapy, Novel Combinations, and Precision Medicine in Patient Care
Matthew S. Davids, MD, MMSc
July 2, 2021
Credits: 1.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
Making Progress in Early and Advanced HER2-Positive Breast Cancer: Leveraging HER2-Targeted Therapies and Modern Care Principles to Improve Clinical Outcomes and Health Equity
Sara Hurvitz, MD
July 2, 2021
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Expanding the Benefits of Checkpoint Inhibitors and Targeted Agents in the Treatment Arsenal for Triple-Negative Breast Cancer
Joyce O’Shaughnessy, MD
July 2, 2021
Credits: 1.25 CME / MOC
Medical Learning Institute, Inc.
Achieving Therapeutic Innovation in ALL: Insights on Modern Asparaginase Compounds in Pediatric, AYA, and Adult Patients
Nicola Gökbuget, MD
June 30, 2021
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
New Standards for CLL Care With BTK Inhibitors: Using Evidence to Make Personalized Treatment Choices
William G. Wierda, MD, PhD
June 29, 2021
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Innovative Immunotherapy in Advanced Basal Cell Carcinoma: Evolving Science, Key Clinical Evidence, and Implications for Multidisciplinary Management
Karl D. Lewis, MD
June 25, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
New and Emerging Therapeutic Strategies in Bladder Cancer: Updates in Early-Stage Disease and Beyond
Matthew D. Galsky, MD
June 23, 2021
Credits: 0.50 CME / MOC
PVI, PeerView Institute for Medical Education
New Data and Clinical Context: An Update on Renal Cell Carcinoma Care in Early Through Advanced Disease
Sumanta Kumar Pal, MD
June 21, 2021
Credits: 0.25 NCPD
Medical Learning Institute, Inc.
Leading the Way in Multiple Myeloma: Nurse Perspectives on Recent Developments With Novel Therapeutics
Beth Faiman, PhD, RN, MSN, ANP-BC, AOCN, FAAN
June 21, 2021
Credits: 0.75 CME / MOC / NCPD
Medical Learning Institute, Inc.
Navigating Shifts in the Treatment Landscape for Metastatic HER2-Positive Breast Cancer: Can New HER2-Targeted Therapies Address Unmet Needs and Offer Better Options for Challenging Patient Populations?
Shanu Modi, MD
June 1, 2021
Credits: 1.00 CME / CC
Medical Learning Institute, Inc.
Immune Checkpoint Inhibitor Therapy for Locally Advanced and Early-Stage Esophageal/GEJ Cancer: The Latest Evidence and Implications for Thoracic Surgeons and the Multidisciplinary Care Team
Ronan J. Kelly, MD, MBA
May 25, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Immunotherapy as a Game-Changer in Multimodal Management of Locally Advanced and Earlier Stages of Lung Cancer
Brendon M. Stiles, MD
May 21, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Meeting Therapeutic Challenges in Pediatric ALL: Expert Perspectives on the Use of Asparaginase Compounds
Elizabeth A. Raetz, MD / Rachel Rau, MD
May 19, 2021
Credits: 1.00 NCPD / ILNA
Medical Learning Institute, Inc.
Changing Times in DLBCL: Oncology Nurse Insight on the Practicalities of Antibody Therapy
Lesley Camille Ballance, MSN, FNP-BC
May 17, 2021
Credits: 1.00 CME / MOC / NCPD / ILNA
Medical Learning Institute, Inc.
The New Therapeutic Era in Renal Cell Carcinoma: Essentials for Team-Based Patient Care
May 17, 2021
Credits: 1.00 NCPD / ILNA
Medical Learning Institute, Inc.
Making Modern Treatment Choices in CLL: Oncology Nurse Insights on the Patient Journey and the New Era of Care
Amy Goodrich, CRNP
May 12, 2021
Credits: 1.00 CPE
Medical Learning Institute, Inc.
Making Sense of the New World of Myeloma Care: Pharmacy Perspectives on Novel Antibodies and BCMA CAR-T Therapy
R. Donald Harvey, BCOP, FCCP, FHOPA
May 12, 2021
Credits: 0.50 CME / NCPD / CPE
Purdue University College of Pharmacy
Analyzing the Pros and Cons of Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology Practice
Evan J. Lipson, MD
May 11, 2021
Credits: 1.00 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Enhancing Personalized Medicine in Advanced Ovarian Cancer: Expert Guidance on Integrating the Latest Updates on PARP Inhibitors and Novel Therapeutic Innovations Into Your Clinical Practice
May 11, 2021

Pages

Education Collections